Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis

Autor: Cano-Pérez C, Mario García-Carrasco, José Rosas, A. Pons-Bas, Bernal-Vidal Ja, Senabre Gallego Jm, Flores-Pardo E, Xavier Barber-Vallés, G. Santos-Soler, M Marco-Mingot, José Alberto García-Gómez, Esteban Salas-Heredia

Publikováno v: Rheumatology International. 39:841-849

Our aim was to assess the relationship between serum adalimumab levels, anti-drug antibodies (ADA) and disease activity in patients with axial spondylarthritis (SpA). We have carried out a single-centre cross-sectional study. adalimumab and ADA level

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dec603ba859f85ac2f0528d0a8852ab
https://doi.org/10.1007/s00296-019-04288-7

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry

Autor: Rosas J, Senabre-Gallego JM, Santos-Soler G, Bernal JA, Pons Bas A, Grupo Aire-Mb

Publikováno v: Reumatologia Clinica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0549b5aee0c33dfd952cf3f1b41d72c6
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8049

Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis

Autor: Senabre Gallego JM, Rosas J, Marco-Mingot M, García-Gómez JA, Santos-Soler G, Salas-Heredia E, Pons-Bas A, Barber-Vallés X, Bernal-Vidal JA, Cano-Pérez C, García-Carrasco M, Flores-Pardo E, AIRE-MB Group

Publikováno v: RHEUMATOLOGY INTERNATIONAL
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica

Our aim was to assess the relationship between serum adalimumab levels, anti-drug antibodies (ADA) and disease activity in patients with axial spondylarthritis (SpA). We have carried out a single-centre cross-sectional study. adalimumab and ADA level

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::194e94ab1793df38f027263dd83ac90e
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6444

AB1413-HPR Advantages of rheumatology nursing vaccination of patients with inflammatory rheumatic diseases of autoimmune origin. analysis of the first 3 years

Autor: A. Pons-Bas, M.A. Lorente, E. Ivars, G. Santos-Soler, Clímaco Cano, E. Salas, Xavier Barber, José Miguel Senabre-Gallego, José Rosas

Publikováno v: Saturday, 16 JUNE 2018.

Background Patients with systemic autoimmune diseases (SAD) have higher incidence of infections. In our Service, until 2014 about 50% of patients did not complete vaccination for pneumococcus or hepatitis B virus (HBV). Objectives To know the charact

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::25972216e1781260fb594676ee8051c7
https://doi.org/10.1136/annrheumdis-2018-eular.4934

SAT0401 Risk of hospital admission due to severe infection in patients under treatment with anti-tnf drugs: data from a local registry

Autor: G. Santos-Soler, Xavier Barber, E. Salas, José Alberto García-Gómez, J. Ena, José Miguel Senabre-Gallego, M. Pucciarelli, E. Ivars, José Rosas, A. Pons-Bas, M.A. Lorente, Clímaco Cano

Publikováno v: Saturday, 16 JUNE 2018.

Objectives To Know characteristics of patients treated with anti-TNF, who suffered infections that forced hospital admission. Methods Prospective observational study in patients treated with anti-TNF, during 1/1/2000 to 12/31/2017, followed up in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d9615aed79aa8bf66e35d26eda21b72
https://doi.org/10.1136/annrheumdis-2018-eular.4971